Publications by authors named "Vadim Kozlov"

Claim this Profile
C
Corrigendum to "Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial" [Eur J Cancer. 227 (2025) 115674].
Lev Demidov, Igor Samoylenko, Galina Kharkevich, Kristina Orlova, Vladimir Moiseenko, Vadim Kozlov

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial.
Lev Demidov, Igor Samoylenko, Galina Kharkevich, Kristina Orlova, Vladimir Moiseenko, Vadim Kozlov

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer.
Yelena Y Janjigian, Salah-Eddin Al-Batran, Zev A Wainberg, Kei Muro, Daniela Molena, Vadim Kozlov

N Engl J Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Ex Vivo Analysis for Examining Cell Composition, Immunological Landscape, Tumor and Immune Related Markers in Non-Small-Cell Lung Cancer.
Elena G Ufimtseva, Margarita S Gileva, Ruslan V Kostenko, Vadim V Kozlov, Lyudmila F Gulyaeva

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking-Mediated miR-301a/IRF1 Axis Controlling Immunotherapy Response in Lung Squamous Cell Carcinoma Revealed by Bioinformatic Analysis.
Alina M Perevalova, Vladislav V Kononchuk, Tatiana S Kalinina, Vadim V Kozlov, Lyudmila F Gulyaeva

Cancers (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Vadim Kozlov

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study.
Viktor Grünwald, Thomas Powles, Evgeny Kopyltsov, Vadim Kozlov, Teresa Alonso-Gordoa

Eur Urol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor suppressor PTEN regulation by tobacco smoke in lung squamous-cell carcinoma based on bioinformatics analysis.
Vladimir O Pustylnyak, Efim Y Alekseenok, Alina M Perevalova, Vadim V Kozlov, Lyudmila F Gulyaeva

Heliyon· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU).
Jonathan E Rosenberg, Se Hoon Park, Vadim Kozlov, Tu V Dao, Daniel Castellano

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cells transfected with a polyepitope DNA construct stimulate an antitumor cytotoxic response in various tumors.
Vasily Kurilin, Ekaterina Kulikova, Julia Shevchenko, Julia Lopatnikova, Irina Obleukhova, Vadim Kozlov

Mol Clin Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Insight into the Role of AhR in Lung Carcinogenesis.
Dinara A Akhmetova, Vadim V Kozlov, Ludmila F Gulyaeva

Biochemistry (Mosc)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer.
Martin J Edelman, Mikhail Dvorkin, Konstatin Laktionov, Alejandro Navarro, Oscar Juan-Vidal, Vadim Kozlov

Lung Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Robert Motzer, Boris Alekseev, Sun-Young Rha, Camillo Porta, Masatoshi Eto, Vadim Kozlov

N Engl J Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of EGFR C797S Mutation in Tyrosine Kinase Inhibitor-Naïve Non-Small Cell Lung Cancer Tissues.
Igor P Oscorbin, Alexandra S Shadrina, Vadim V Kozlov, Vladimir E Voitsitsky, Maxim L Filipenko

Pathol Oncol Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycoplasma hyorhinis reduces sensitivity of human lung carcinoma cells to Nutlin-3 and promotes their malignant phenotype.
Uljana A Boyarskikh, Alexandra S Shadrina, Mariya A Smetanina, Yakov A Tsepilov, Igor P Oscorbin, Vadim V Kozlov

J Cancer Res Clin Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased expression of miR-155 and miR-222 is associated with lymph node positive status.
Vladimir Chernyy, Vladimir Pustylnyak, Vadim Kozlov, Lyudmila Gulyaeva

J Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of antigen-primed dendritic cells for inducing antitumor immune responses in patients with non-small cell lung cancer.
Irina Obleukhova, Nataliya Kiryishina, Svetlana Falaleeva, Julia Lopatnikova, Vasiliy Kurilin, Vadim Kozlov

Oncol Lett· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variety of RNAs in Peripheral Blood Cells, Plasma, and Plasma Fractions.
Anna V Savelyeva, Elena V Kuligina, Dmitry N Bariakin, Vadim V Kozlov, Elena I Ryabchikova

Biomed Res Int· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis